28Feb 2022
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients

Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients

Semin Respir Crit Care Med 2022; 43: 046-059
DOI: 10.1055/s-0041-1741009

Invasive candidiasis (IC) has become a serious problem in the intensive care unit patients with an attributable mortality rate that can reach up to 51%. Multiple global surveillance studies have shown an increasing incidence of candidemia. Despite their limited sensitivity (21–71%), cultures remain the gold standard for the diagnosis of IC associated with candidemia. There is no consensus concerning the benefit of prophylactic therapy in critically ill patients. Due to the conflicting results of the various studies on the benefit of preemptive therapy for critically ill patients and the lack of robust evidence, the Infectious Diseases Society of America (IDSA) omitted this category from its updated guidelines and the European Society of Intensive Care Medicine (ESICM) and the Critically Ill Patients Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) do not recommend it.

  • #critical care

Like

Save

Share